Enhanced BMP Signaling Alters Human β-Cell Identity and Function.

Area of Science:

• Endocrinology
• Cell Biology
• Immunology

Background:

• Inflammation is a key factor in diabetes development.
• Pancreatic beta-cell dysfunction and loss contribute to diabetes pathophysiology.
• Bone morphogenetic protein (BMP) signaling is implicated in beta-cell function and identity.

Purpose of the Study:

• To investigate the role of BMP signaling in inflammation-induced pancreatic beta-cell failure.
• To determine if inflammatory cytokines activate BMP signaling in beta-cells.
• To explore BMP signaling as a therapeutic target for preserving beta-cell mass in diabetes.

Main Methods:

• Single-cell transcriptomics analysis of human islets.
• Quantitative PCR (qPCR) validation.
• Treatment with inflammatory cytokines (IL-1β+IFNγ, IFNα) and recombinant BMP2/4.

Main Results:

• Inflammatory cytokine treatment activated BMP signaling in beta-cells.
• Enhanced BMP signaling reduced the expression of key beta-cell maturity genes.
• Increased ER stress and impaired beta-cell function were observed with enhanced BMP signaling.

Conclusions:

• Inflammation-activated BMP signaling is detrimental to pancreatic beta-cells.
• BMP signaling pathways are critical in inflammation-induced beta-cell failure.
• Targeting BMP signaling offers a potential strategy to protect beta-cells in a pro-inflammatory environment.